Nuo Therapeutics (AURX) Net Income towards Common Stockholders (2009 - 2026)
Nuo Therapeutics (AURX) posted Net Income towards Common Stockholders of -$424,928 for Q3 2026, compared with -$537,919 a year earlier.
Nuo Therapeutics (AURX) Net Income towards Common Stockholders (2009 - 2026) Analysis & Trends
For the trailing twelve months through Sep 30, 2026, Net Income towards Common Stockholders at Nuo Therapeutics was -$1.9 million; for FY2025, it came in at -$2.51 million.
- In prior years, Nuo Therapeutics' Net Income towards Common Stockholders was -$2.32 million in FY2024, -$3.17 million in FY2023, -$3.17 million in FY2022 and -$886,262 in FY2021.
- Quarterly Net Income towards Common Stockholders has run from a low of -$959,517 in Q4 2022 to a high of -$277,601 in Q2 2026 over five years.
- According to Business Quant data, Net Income towards Common Stockholders for the three prior quarters was -$277,601 (Q2 2026), -$618,466 (Q1 2026) and -$578,480 (Q4 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Income (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 247.92 Bn | 224.44 Bn | 5.13 Bn | 1.72 Bn |
| 2 | Abbott Laboratories | 178.73 Bn | 152.60 Bn | 7.39 Bn | 920.00 Mn |
| 3 | Danaher | 155.17 Bn | 134.82 Bn | 3.84 Bn | 1.24 Bn |
| 4 | Intuitive Surgical | 139.71 Bn | 120.00 Bn | 2.08 Bn | 522.80 Mn |
| 5 | Medtronic | 127.92 Bn | 93.17 Bn | 6.34 Bn | 1.47 Bn |
| 6 | Stryker | 118.34 Bn | 104.53 Bn | 4.25 Bn | 753.00 Mn |
| 7 | Boston Scientific | 61.10 Bn | 56.53 Bn | 3.43 Bn | 582.00 Mn |
| 8 | Edwards Lifesciences | 58.81 Bn | 42.02 Bn | 1.35 Bn | 301.40 Mn |
| 9 | Agilent Technologies | 47.86 Bn | 40.75 Bn | 1.04 Bn | 362.00 Mn |
| 10 | Nuo Therapeutics | 44.28 Bn | 44.28 Bn | 1.19 Mn | -424,928.00 |
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | -424,928.00 |
| Jun 30, 2026 | -277,601.00 |
| Mar 31, 2026 | -618,466.00 |
| Dec 31, 2025 | -578,480.00 |
| Sep 30, 2025 | -537,919.00 |
| Jun 30, 2025 | -649,689.00 |
| Mar 31, 2025 | -746,128.00 |
| Dec 31, 2024 | -496,666.00 |
| Sep 30, 2024 | -578,167.00 |
| Jun 30, 2024 | -540,091.00 |
| Mar 31, 2024 | -708,781.00 |
| Dec 31, 2023 | -653,155.00 |
| Sep 30, 2023 | -790,640.00 |
| Jun 30, 2023 | -871,886.00 |
| Mar 31, 2023 | -855,755.00 |
| Dec 31, 2022 | -959,517.00 |
| Sep 30, 2022 | -912,789.00 |
| Jun 30, 2022 | -924,050.00 |
| Mar 31, 2022 | -375,380.00 |
| Dec 31, 2021 | -886,262.00 |
Nuo Therapeutics Net Income towards Common Stockholders API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=net-income-towards-common-stockholders&ticker=AURX&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "net-income-towards-common-stockholders", "ticker": "AURX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=net-income-towards-common-stockholders&ticker=AURX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();